Palmitoyl Tripeptide-1 vs Thymulin
A detailed comparison to help you understand the differences and choose the right peptide for your research goals.
Palmitoyl Tripeptide-1
Palmitoyl Tripeptide-1 (Pal-GHK) is a lipopeptide that stimulates collagen production. It's one of two peptides in the Matrixyl 3000 complex, working synergistically with Palmitoyl Tetrapeptide-7.
Full details →Thymulin
Thymulin (Facteur Thymique Sérique) is a zinc-dependent nonapeptide hormone produced by thymic epithelial cells. It plays important roles in T-cell differentiation and immune system maturation.
Full details →Side-by-Side Comparison
| Aspect | Palmitoyl Tripeptide-1 | Thymulin |
|---|---|---|
| Dose Range | 500 mcg–2 mg | 100 mcg–400 mcg |
| Frequency | 2x daily | 1x daily |
| Cycle Length | 4–12 weeks | 4–8 weeks |
| Route | topical | subcutaneous |
| Mechanism | Mimics the skin's own mechanism for producing collagen by acting as a messenger peptide that signals fibroblasts to produce more collagen and other extracellular matrix components. | Requires zinc for biological activity. Promotes T-cell differentiation, modulates cytokine production, and influences neuroendocrine function. Levels decline significantly with age. |
| Typical Dosage | Topical: Typically 2-4% in serums, often combined with Palmitoyl Tetrapeptide-7 as Matrixyl 3000. | Research protocols vary. Often studied alongside zinc supplementation. Typical research doses in the microgram range. |
| Administration | Topical application 1-2 times daily. The palmitoyl group enhances skin penetration compared to non-lipidated versions. | Subcutaneous or intramuscular injection in research settings. Requires adequate zinc status for activity. |
| Side Effects | Very well-tolerated. Suitable for most skin types including sensitive skin. | Limited data on exogenous administration. Theoretical effects on immune function require monitoring. |
| Best For |
What They Have in Common
Palmitoyl Tripeptide-1, Thymulin are both commonly used for:
Key Differences
Unique to Palmitoyl Tripeptide-1:
Unique to Thymulin:
Which Has Stronger Evidence?
| Goal | Palmitoyl Tripeptide-1 | Thymulin |
|---|---|---|
| Anti-Aging & Longevity | medium | medium |
Key Studies
Thymulin
- Thymulin restrains age-associated myeloid inflammation and enhances cancer immunotherapy.
Nature communications, 2026
- Thymulin and peroxiredoxin 6 have protective effects against streptozotocin-induced type 1 diabetes in mice.
International journal of immunopathology and pharmacology, 2021
- Nanoparticle-based thymulin gene therapy therapeutically reverses key pathology of experimental allergic asthma.
Science advances, 2020
Ready to Learn More?
Looking for trusted sources?